| 11/10/2026 3:26 PM | Corcept Therapeutics (1088856) Subject Swisher Daniel N JR (1323113) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/04/2026 6:20 PM | Corcept Therapeutics (1088856) Issuer Vieira Roberto Wandenkolk (2150104) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/04/2026 6:26 PM | Corcept Therapeutics (1088856) Issuer Maduck Sean (1698310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/03/2026 3:09 PM | Corcept Therapeutics (1088856) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/03/2026 3:11 PM | Corcept Therapeutics (1088856) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/27/2026 4:25 PM | BlackRock, Inc. (2012383) Filed by Corcept Therapeutics (1088856) Subject | Form SCHEDULE 13G/A | |
| 10/16/2026 5:24 PM | Corcept Therapeutics (1088856) Issuer WILSON JAMES N (1236387) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/05/2026 6:54 PM | Corcept Therapeutics (1088856) Issuer Lyon Joseph Douglas (1817838) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/05/2026 6:58 PM | Corcept Therapeutics (1088856) Issuer Vieira Roberto Wandenkolk (2150104) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/05/2026 6:44 PM | Corcept Therapeutics (1088856) Issuer Gunn Justin Frederick (2155454) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/05/2026 6:49 PM | Corcept Therapeutics (1088856) Issuer Maduck Sean (1698310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CORT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Corcept Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/05/2026 6:18 PM | Corcept Therapeutics (1088856) Issuer Gunn Justin Frederick (2155454) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/01/2026 10:09 AM | Corcept Therapeutics (1088856) Subject Lyon Joseph Douglas (1817838) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/28/2026 3:30 PM | Corcept Therapeutics (1088856) Issuer Robb Gary Charles (1529655) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2026 7:15 AM | Corcept Therapeutics (1088856) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/18/2026 6:53 PM | Corcept Therapeutics (1088856) Issuer Vieira Roberto Wandenkolk (2150104) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 6:47 PM | Corcept Therapeutics (1088856) Issuer Robb Gary Charles (1529655) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2026 3:30 PM | Corcept Therapeutics (1088856) Issuer WILSON JAMES N (1236387) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2026 3:30 PM | Corcept Therapeutics (1088856) Issuer Lyon Joseph Douglas (1817838) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 9:23 AM | Corcept Therapeutics (1088856) Subject WILSON JAMES N (1236387) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/14/2026 12:58 PM | Corcept Therapeutics (1088856) Subject Lyon Joseph Douglas (1817838) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/03/2026 8:16 PM | Corcept Therapeutics (1088856) Issuer Maduck Sean (1698310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/03/2026 8:16 PM | Corcept Therapeutics (1088856) Issuer Guyer William (1879013) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/03/2026 8:00 PM | Corcept Therapeutics (1088856) Issuer Lyon Joseph Douglas (1817838) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/03/2026 8:02 PM | Corcept Therapeutics (1088856) Issuer Vieira Roberto Wandenkolk (2150104) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/03/2026 8:03 PM | Corcept Therapeutics (1088856) Issuer Robb Gary Charles (1529655) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/03/2026 8:06 PM | Corcept Therapeutics (1088856) Issuer Mokari Atabak (1678419) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/03/2026 7:39 PM | Corcept Therapeutics (1088856) Issuer Vieira Roberto Wandenkolk (2150104) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 08/27/2026 3:30 PM | Corcept Therapeutics (1088856) Issuer Maduck Sean (1698310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/26/2026 3:14 PM | Corcept Therapeutics (1088856) Subject Park Kimberly (1788208) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/25/2026 4:24 PM | Corcept Therapeutics (1088856) Subject Maduck Sean (1698310) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/20/2026 3:30 PM | Corcept Therapeutics (1088856) Issuer MAHONEY DAVID L (1224091) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2026 3:30 PM | Corcept Therapeutics (1088856) Issuer Robb Gary Charles (1529655) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2026 3:30 PM | Corcept Therapeutics (1088856) Issuer WILSON JAMES N (1236387) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2026 3:30 PM | Corcept Therapeutics (1088856) Issuer Maduck Sean (1698310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2026 9:12 AM | Corcept Therapeutics (1088856) Subject MAHONEY DAVID L (1224091) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/17/2026 3:05 PM | Corcept Therapeutics (1088856) Subject Robb Gary Charles (1529655) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/14/2026 3:31 PM | Corcept Therapeutics (1088856) Issuer Robb Gary Charles (1529655) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/13/2026 3:20 PM | Corcept Therapeutics (1088856) Subject RENAISSANCE TECHNOLOGIES LLC (1037389) Filed by | Form SCHEDULE 13G/A | |
| 08/12/2026 3:27 PM | Corcept Therapeutics (1088856) Issuer Maduck Sean (1698310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/06/2026 5:44 PM | Corcept Therapeutics (1088856) Issuer Guyer William (1879013) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Your Copy is on Hold (Claim it now) (Ad) James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play.
He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60.
Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date. Claim your copy of James Altucher's new Elon Musk report today. |
| 08/05/2026 4:48 PM | Corcept Therapeutics (1088856) Issuer Lyon Joseph Douglas (1817838) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2026 4:51 PM | Corcept Therapeutics (1088856) Issuer Maduck Sean (1698310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/04/2026 2:07 PM | Corcept Therapeutics (1088856) Subject Guyer William (1879013) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/03/2026 11:16 AM | Corcept Therapeutics (1088856) Subject Lyon Joseph Douglas (1817838) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/30/2026 3:03 PM | Corcept Therapeutics (1088856) Subject Mokari Atabak (1678419) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/17/2026 5:38 PM | Corcept Therapeutics (1088856) Issuer WILSON JAMES N (1236387) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/17/2026 5:31 PM | Corcept Therapeutics (1088856) Issuer Mokari Atabak (1678419) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/08/2026 6:54 PM | Corcept Therapeutics (1088856) Issuer Guyer William (1879013) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/08/2026 7:01 PM | Corcept Therapeutics (1088856) Issuer Robb Gary Charles (1529655) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/07/2026 10:12 AM | Corcept Therapeutics (1088856) Subject Guyer William (1879013) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/06/2026 3:44 PM | Corcept Therapeutics (1088856) Issuer Maduck Sean (1698310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2026 3:30 PM | Corcept Therapeutics (1088856) Issuer MAHONEY DAVID L (1224091) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2026 3:30 PM | Corcept Therapeutics (1088856) Issuer WILSON JAMES N (1236387) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 3:30 PM | Corcept Therapeutics (1088856) Issuer Mokari Atabak (1678419) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 3:36 PM | Corcept Therapeutics (1088856) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/16/2026 2:06 PM | Corcept Therapeutics (1088856) Subject MAHONEY DAVID L (1224091) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/16/2026 12:55 PM | Corcept Therapeutics (1088856) Subject WILSON JAMES N (1236387) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/04/2026 3:49 PM | Corcept Therapeutics (1088856) Issuer Guyer William (1879013) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 6:24 PM | Corcept Therapeutics (1088856) Issuer Guyer William (1879013) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 6:28 PM | Corcept Therapeutics (1088856) Issuer Lyon Joseph Douglas (1817838) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 6:15 PM | Corcept Therapeutics (1088856) Issuer Robb Gary Charles (1529655) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 6:20 PM | Corcept Therapeutics (1088856) Issuer Mokari Atabak (1678419) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 6:20 PM | Corcept Therapeutics (1088856) Issuer Maduck Sean (1698310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 7:00 AM | Corcept Therapeutics (1088856) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/02/2026 3:05 PM | BELANOFF JOSEPH K (1286199) Reporting Corcept Therapeutics (1088856) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 1:25 PM | Corcept Therapeutics (1088856) Subject Guyer William (1879013) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/01/2026 4:50 PM | Corcept Therapeutics (1088856) Subject Mokari Atabak (1678419) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/01/2026 10:40 AM | BELANOFF JOSEPH K (1286199) Reporting Corcept Therapeutics (1088856) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/29/2026 5:11 PM | Corcept Therapeutics (1088856) Issuer Lyon Joseph Douglas (1817838) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:56 PM | Corcept Therapeutics (1088856) Issuer WILSON JAMES N (1236387) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 5:03 PM | Corcept Therapeutics (1088856) Issuer Maduck Sean (1698310) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 3:04 PM | Corcept Therapeutics (1088856) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/27/2026 5:07 PM | Corcept Therapeutics (1088856) Subject Maduck Sean (1698310) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/26/2026 4:39 PM | Alton Gregg H (1334682) Reporting Corcept Therapeutics (1088856) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 4:40 PM | BAKER G LEONARD JR (1201715) Reporting Corcept Therapeutics (1088856) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 4:28 PM | Corcept Therapeutics (1088856) Issuer Park Kimberly (1788208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 4:31 PM | Corcept Therapeutics (1088856) Issuer MAHONEY DAVID L (1224091) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 4:33 PM | Corcept Therapeutics (1088856) Issuer Murray Joshua M. (1867952) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 4:35 PM | Corcept Therapeutics (1088856) Issuer Swisher Daniel N JR (1323113) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 4:36 PM | Corcept Therapeutics (1088856) Issuer WILSON JAMES N (1236387) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/20/2026 11:46 AM | Corcept Therapeutics (1088856) Subject Lyon Joseph Douglas (1817838) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/15/2026 5:59 PM | Corcept Therapeutics (1088856) Issuer Robb Gary Charles (1529655) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 3:30 PM | Corcept Therapeutics (1088856) Issuer Guyer William (1879013) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 10:13 AM | Corcept Therapeutics (1088856) Subject Guyer William (1879013) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/01/2026 11:30 AM | BELANOFF JOSEPH K (1286199) Reporting Corcept Therapeutics (1088856) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/24/2026 3:30 PM | Corcept Therapeutics (1088856) Issuer WILSON JAMES N (1236387) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 3:20 PM | Corcept Therapeutics (1088856) Subject INGALLS & SNYDER LLC (1041885) Filed by | Form SCHEDULE 13G/A | |
| 04/08/2026 6:29 PM | Corcept Therapeutics (1088856) Issuer WILSON JAMES N (1236387) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/08/2026 6:34 PM | Corcept Therapeutics (1088856) Issuer Guyer William (1879013) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/07/2026 11:08 AM | Corcept Therapeutics (1088856) Subject Guyer William (1879013) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Your Copy is on Hold (Claim it now) (Ad) James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play.
He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60.
Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date. Claim your copy of James Altucher's new Elon Musk report today. |
| 03/27/2026 3:27 PM | BELANOFF JOSEPH K (1286199) Reporting Corcept Therapeutics (1088856) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/26/2026 4:43 PM | Corcept Therapeutics (1088856) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/25/2026 2:49 PM | BELANOFF JOSEPH K (1286199) Reporting Corcept Therapeutics (1088856) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/25/2026 12:31 PM | Corcept Therapeutics (1088856) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/24/2026 3:54 PM | Corcept Therapeutics (1088856) Issuer Guyer William (1879013) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 3:55 PM | Corcept Therapeutics (1088856) Issuer WILSON JAMES N (1236387) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/19/2026 4:07 PM | BAKER G LEONARD JR (1201715) Reporting Corcept Therapeutics (1088856) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 7:03 PM | Corcept Therapeutics (1088856) Issuer WILSON JAMES N (1236387) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 6:52 PM | Corcept Therapeutics (1088856) Issuer MAHONEY DAVID L (1224091) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |